Joshua M. Levy, M.D., M.P.H., M.S., Chief
Research Statement
The Sinonasal and Olfaction Program is a multi-specialty team with diversity in thought, background, and training. Collectively, we seek to translate emerging basic science discoveries into impactful advances in patient care. Specific focuses include point-of-care diagnostics, post-viral olfactory dysfunction, and the role of endogenous cannabinoids in chronic airway inflammation in aspirin-exacerbated respiratory disease (AERD) and other forms of nasal polyps.